ES2104044T3 - Capsulas blandas revestidas entericas y metodo para su produccion. - Google Patents

Capsulas blandas revestidas entericas y metodo para su produccion.

Info

Publication number
ES2104044T3
ES2104044T3 ES93202463T ES93202463T ES2104044T3 ES 2104044 T3 ES2104044 T3 ES 2104044T3 ES 93202463 T ES93202463 T ES 93202463T ES 93202463 T ES93202463 T ES 93202463T ES 2104044 T3 ES2104044 T3 ES 2104044T3
Authority
ES
Spain
Prior art keywords
mixture
soft capsules
weight
entericas
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93202463T
Other languages
English (en)
Inventor
Shrikant Narayan Pagay
Gregg Stetsko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2104044T3 publication Critical patent/ES2104044T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN UNAS CAPSULAS BLANDAS PROTEGIDAS CON 1 A 20 MG/CM2 DE UN PROTECTOR ENTERICO ESENCIALMENTE CON UN PESO DE 60 A 90% DE UN COPOLIMERO 1:1 DE ACIDO DE METACRILATO Y ACRILATO METILO O ETILO O METACRILATO ETILO O METILO Y DE 10 A 40% DE UN PLASTIFICANTE SELECCIONADO DEL GRUPO CONSISTENTE EN TRIACENTINO, CITRATO TRIETILO Y EFTALATO DIBUTILO O MEZCLA DE LOS MISMOS, SIN LA NECESIDAD DE UN SUBPROTECTOR, Y OPCIONALMENTE UN PROTECTOR ADICIONAL CON DE 1 A 10 MG/CM2, CONSISTENTE EN 60 A 90% EN PESO DE UN DERIVADO DE CELULOSA QUE ES METILCELULOSA HIDROXIPROPILO O CELULOSA HIDROXIPROPLILO O MEZCLA DE AMBAS, Y DE 10 A 40% DE UN PLASTIFICANTE SELECCIONADO DE UN GRUPO CONSISTENTE EN TRIACETINO, GLICOL POLIETILENO CON UN PESO MOLECULAR DE 400 A 3350, GLICOL PROPILENO, EFTALATO DIBUTILO, CITRATO TRIETILO, GLICERINA Y MONOGLICERIDOS DIACETILADOS O MEZCLA. DESCRITO EL METODO DE PREPARACION.
ES93202463T 1992-08-26 1993-08-21 Capsulas blandas revestidas entericas y metodo para su produccion. Expired - Lifetime ES2104044T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/935,505 US5330759A (en) 1992-08-26 1992-08-26 Enteric coated soft capsules and method of preparation thereof

Publications (1)

Publication Number Publication Date
ES2104044T3 true ES2104044T3 (es) 1997-10-01

Family

ID=25467257

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93202463T Expired - Lifetime ES2104044T3 (es) 1992-08-26 1993-08-21 Capsulas blandas revestidas entericas y metodo para su produccion.

Country Status (12)

Country Link
US (1) US5330759A (es)
EP (1) EP0587220B1 (es)
JP (1) JP3983823B2 (es)
AT (1) ATE152618T1 (es)
AU (1) AU672982B2 (es)
CA (1) CA2101095C (es)
DE (1) DE69310461T2 (es)
DK (1) DK0587220T3 (es)
ES (1) ES2104044T3 (es)
GR (1) GR3024351T3 (es)
HU (1) HUT64833A (es)
MX (1) MX9305108A (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US6224911B1 (en) * 1993-03-16 2001-05-01 Syntex (U.S.A.) Llc Process for the preparation of enteric coated pharmaceutical dosage forms
MX9600857A (es) * 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
JP3625940B2 (ja) * 1996-01-29 2005-03-02 信越化学工業株式会社 水系液のカプセルおよびその製造方法
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6440448B1 (en) 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US6139875A (en) * 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
US20090297597A1 (en) * 1998-11-02 2009-12-03 Gary Liversidge Modified Release Ticlopidine Compositions
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US20070122481A1 (en) * 1998-11-02 2007-05-31 Elan Corporation Plc Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer
NZ511442A (en) * 1998-11-02 2003-02-28 Elan Corp Plc Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl
GB9824658D0 (en) * 1998-11-11 1999-01-06 Brown Malcolm D A capsule based drug delivery system
KR20020059653A (ko) 1999-10-29 2002-07-13 그린 마틴, 브라이언 쥐 테슬리 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP1337244A4 (en) 2000-10-30 2006-01-11 Euro Celtique Sa HYDROCODON FORMULATIONS WITH CONTROLLED RELEASE
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
DK1545475T3 (da) 2002-10-01 2014-07-28 Banner Pharmacaps Inc Enterisk sammensætning til fremstillingen af blød kapselvæg
US20080220074A1 (en) * 2002-10-04 2008-09-11 Elan Corporation Plc Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
US20050152969A1 (en) * 2004-01-08 2005-07-14 Chiprich Timothy B. Colored liquid-filled soft capsules and method of manufacture thereof
US20060121112A1 (en) * 2004-12-08 2006-06-08 Elan Corporation, Plc Topiramate pharmaceutical composition
US20070298098A1 (en) * 2005-02-16 2007-12-27 Elan Pharma International Limited Controlled Release Compositions Comprising Levetiracetam
CA2602268A1 (en) * 2005-04-12 2006-10-19 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
US20070148248A1 (en) 2005-12-22 2007-06-28 Banner Pharmacaps, Inc. Gastric reflux resistant dosage forms
DK2219621T3 (da) 2007-11-12 2014-03-31 Pharmaceutics International Inc Trimolekylære komplekser og anvendelse heraf i systemer til indgivelse aflægemidler
WO2009136493A1 (ja) * 2008-05-08 2009-11-12 パナソニック株式会社 不揮発性記憶素子、及び、不揮発性記憶素子又は不揮発性記憶装置の製造方法
RU2011150266A (ru) * 2009-05-12 2013-06-20 БиПиЭсАй ХОЛДИНГЗ, ЭлЭлСи. Пленочные покрытия, содержащие тонкодисперсные вещества против клейкости, и субстраты, покрытые этой пленкой
WO2010132204A1 (en) * 2009-05-12 2010-11-18 Bpsi Holdings, Llc. Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
US8663671B2 (en) 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
CA2868362C (en) 2012-03-29 2018-07-31 Jerome Schentag Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
US9907755B2 (en) * 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
SI2946774T1 (sl) * 2014-05-19 2020-07-31 Tillotts Pharma Ag Obložene kapsule s prirejenim sproščanjem
WO2015200149A1 (en) 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
EP3244878B1 (en) * 2015-01-12 2022-08-10 Enteris BioPharma, Inc. Solid oral dosage forms
CN104825418B (zh) * 2015-05-07 2018-05-15 上海信谊万象药业股份有限公司 一种硝苯地平软胶丸及其制备方法
US9993426B2 (en) 2015-09-15 2018-06-12 C. B. Fleet Company, Inc. Bisacodyl compositions and delivery apparatus
AU2019334555B2 (en) 2018-09-05 2025-02-20 Renapharma AB An iron containing composition and use thereof
AU2020268767B8 (en) 2019-05-07 2025-08-07 Bausch Health Ireland Limited Liquid oral dosage formulations of methylnaltrexone
CA3177250A1 (en) 2020-05-02 2021-11-11 Bausch Health Ireland Limited Methods of reducing mortality risk in subjects suffering from an underlying disease or condition by administration of methylnaltrexone
EP4169503A1 (en) 2021-10-20 2023-04-26 Tessenderlo Group NV Composition comprising gelatin, gelatin films and capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3234331C2 (de) * 1982-09-16 1986-06-05 A. Nattermann & Cie GmbH, 5000 Köln Verfahren und Lösungen zum Beschichten von Gelatinekapseln mit magensaftresistenten Überzügen
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
JP2782691B2 (ja) * 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
US5047258A (en) * 1989-07-14 1991-09-10 Sterling Drug Inc. Aqueous spray-coating process
NL9002336A (nl) * 1990-10-24 1992-05-18 Leuven K U Res & Dev Bekledings- of matrixmateriaal voor geneesmiddelen.

Also Published As

Publication number Publication date
HU9302426D0 (en) 1993-11-29
MX9305108A (es) 1994-02-28
DK0587220T3 (da) 1997-12-01
DE69310461T2 (de) 1997-12-11
EP0587220A1 (en) 1994-03-16
EP0587220B1 (en) 1997-05-07
AU672982B2 (en) 1996-10-24
JP3983823B2 (ja) 2007-09-26
CA2101095C (en) 2004-01-20
DE69310461D1 (de) 1997-06-12
US5330759A (en) 1994-07-19
ATE152618T1 (de) 1997-05-15
JPH06157295A (ja) 1994-06-03
HUT64833A (en) 1994-03-28
GR3024351T3 (en) 1997-11-28
AU4488893A (en) 1994-03-03
CA2101095A1 (en) 1994-02-27

Similar Documents

Publication Publication Date Title
ES2104044T3 (es) Capsulas blandas revestidas entericas y metodo para su produccion.
US5112621A (en) Sustained release pharmaceutical composition of diltiazem
US5834023A (en) Diltiazem controlled release formulation
US5364620A (en) Controlled absorption diltiazem formulation for once daily administration
AU639519B2 (en) Controlled absorption naproxen formulation for once-daily administration
RU2004121786A (ru) Лекарственные составы длительного высвобождения, содержащие в качестве активного соединения венлафаксина гидрохлорид
RU2011101918A (ru) Получение лекарственных форм миорелаксантов скелетных мышц с контролируемым высвобождением
KR920002135A (ko) 대장에서만 방출할수 있는 피복시킨 고체 약물형태
NO975218D0 (no) Behandling av inflammatorisk tarmsykdom ved bruk av orale doseringsformer av omega-3-polyumettede syrer
KR920702618A (ko) 약제학적 제형
AR069500A1 (es) Metodos de tratamiento de la esteatohepatitis no alcoholica (nash ) utilizando productos de cisteamina
EA023971B1 (ru) Применение композиции, содержащей покрытые энтеросолюбильной оболочкой цистамин или цистеамин, для лечения цистиноза и способ лечения цистиноза
JPS57171428A (en) Preparation of coated solid preparation
CO5271674A1 (es) Particulas farmaceuticas con enmascaramiento de sabor
BG50712A3 (bg) Метод за получаване на покритие на фармацевтичен препарат с контролирано освобождаване на активното вещество
KR920019360A (ko) 담즙산과 그 염을 함유하는 경구용 제어 방출 위 내성 의약 포뮬레이션
FI821422A0 (fi) Foerfarande foer framstaellning av ett nytt farmaceutiskt preparat
CA2466726A1 (en) Preparation composition containing acid-unstable physiologically active compound and process for producing same
ATE25670T1 (de) 5-aminosalicylsaeure-o-sulfate von physiologisch unbedenklichen basen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
JPS53133625A (en) Manufacturing of pharmaceutical coated with enteric film
IL151150A (en) A multiparticulate form of a drug containing at least two different forms of coated tablets
KR20000053327A (ko) 결장내 운반에 사용되는 약학적 제형
KR940001887A (ko) 신규 경구제형
KR960013372A (ko) 경구용 오메프라졸 제제
EP1060743A1 (en) Oral cisapride dosage forms with an extended duration

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 587220

Country of ref document: ES